Bio-Techne Corporation

50.19
1.11 (2.26%)
At close: Apr 23, 2025, 3:59 PM
50.76
1.14%
After-hours: Apr 23, 2025, 06:00 PM EDT

Bio-Techne Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Consumables Revenue 230.84M 245.78M 246.73M 211.13M 224.55M
Consumables Revenue Growth -6.07% -0.39% +16.86% -5.98% n/a
Instruments Revenue 26.21M 27.09M 26.49M 29.82M 24.86M
Instruments Revenue Growth -3.27% +2.26% -11.17% +19.97% n/a
Royalty Revenue 5.05M 5.05M 4.7M 7.52M 6.07M
Royalty Revenue Growth -0.02% +7.42% -37.46% +23.77% n/a

Revenue by Geography

Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2014 Jun 30, 2013 Jun 30, 2012
Apac, Excluding Greater China Revenue 73.9M 73.19M 18.88M 14.11M 11.38M
Apac, Excluding Greater China Revenue Growth +0.98% +287.70% +33.83% +23.98% n/a
Europe Revenue 241.43M 220.23M 97.16M 88.3M 90.14M
Europe Revenue Growth +9.63% +126.67% +10.03% -2.05% n/a
C N Revenue 99.47M 113.87M 18.66M 15.26M 14.74M
C N Revenue Growth -12.65% +510.06% +22.35% +3.49% n/a
Rest Of World Revenue 36.5M 37.49M 190.36M 164.31M 172.31M
Rest Of World Revenue Growth -2.65% -80.30% +15.85% -4.64% n/a
United Kingdom Revenue 50.01M 49.46M n/a n/a n/a
United Kingdom Revenue Growth +1.12% n/a n/a n/a n/a
U S Revenue 657.75M 642.47M n/a n/a n/a
U S Revenue Growth +2.38% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 121.45M 119.16M 101.9M 107.5M 115.67M 105.33M 86.75M 99.24M 93.01M 99.38M 96.63M 89.27M 100.69M 86.17M 86.64M 82.6M 83.12M 72.6M 57.22M 66.32M 68.03M 69.01M 68.74M 64.97M 63.6M 67.05M 65.29M 53.28M 63.77M 58.29M 47.2M 48.11M 55.66M 46.26M 38.04M 35.22M 34.59M 33.04M 30.47M 29.09M
Selling, General, and Administrative Revenue Growth +1.92% +16.94% -5.22% -7.06% +9.81% +21.41% -12.58% +6.70% -6.41% +2.84% +8.25% -11.35% +16.85% -0.54% +4.90% -0.63% +14.49% +26.87% -13.71% -2.52% -1.42% +0.40% +5.80% +2.15% -5.14% +2.70% +22.52% -16.45% +9.41% +23.50% -1.89% -13.56% +20.30% +21.63% +8.01% +1.83% +4.68% +8.42% +4.76% n/a
Research and Development Revenue 25.02M 23.87M 23.99M 25.76M 22.92M 24M 23.42M 22.71M 22.46M 23.9M 23.15M 21.74M 20.65M 21.6M 20.72M 17.05M 16.79M 16.04M 16.78M 15.95M 16.38M 16.08M 16.26M 15.55M 15.81M 14.79M 13.98M 13.89M 13.91M 13.55M 13.7M 13.77M 13.28M 12.77M 11.64M 11.24M 10.98M 11.32M 10.81M 10.87M
Research and Development Revenue Growth +4.81% -0.50% -6.88% +12.41% -4.51% +2.48% +3.10% +1.13% -6.04% +3.26% +6.47% +5.29% -4.40% +4.24% +21.52% +1.57% +4.66% -4.40% +5.17% -2.61% +1.89% -1.12% +4.55% -1.64% +6.92% +5.79% +0.63% -0.14% +2.68% -1.09% -0.54% +3.69% +4.04% +9.64% +3.54% +2.44% -3.05% +4.71% -0.48% n/a